Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA003413-13
Application #
2116750
Study Section
Drug Abuse Clinical and Behavioral Research Review Committee (DACB)
Project Start
1984-07-01
Project End
1998-06-30
Budget Start
1996-07-01
Budget End
1998-06-30
Support Year
13
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Emory University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Jain, Raka; Holtzman, Stephen G (2005) Caffeine induces differential cross tolerance to the amphetamine-like discriminative stimulus effects of dopaminergic agonists. Brain Res Bull 65:415-21
Powell, K R; Iuvone, P M; Holtzman, S G (2001) The role of dopamine in the locomotor stimulant effects and tolerance to these effects of caffeine. Pharmacol Biochem Behav 69:59-70
Holtzman, S G (1999) Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, have a dopamine component in monkeys. Eur J Pharmacol 376:7-15
Powell, K R; Holtzman, S G (1998) Lack of NMDA receptor involvement in caffeine-induced locomotor stimulation and tolerance in rats. Pharmacol Biochem Behav 59:433-8
Easterling, K W; Holtzman, S G (1997) Parametric changes in response equilibrium during an intra-cranial self stimulation (ICSS) task: can reward value be assessed independently of absolute threshold? Neurosci Biobehav Rev 21:55-65
Holtzman, S G (1996) Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, in monkeys: comparison to methylxanthines. J Pharmacol Exp Ther 277:739-46
Garrett, B E; Holtzman, S G (1996) Comparison of the effects of prototypical behavioral stimulants on locomotor activity and rotational behavior in rats. Pharmacol Biochem Behav 54:469-77
(1996) Caffeine: a model drug of abuse. NIDA Res Monogr 162:73-5
Garrett, B E; Holtzman, S G (1995) Does adenosine receptor blockade mediate caffeine-induced rotational behavior? J Pharmacol Exp Ther 274:207-14
Garrett, B E; Holtzman, S G (1994) Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction. Eur J Pharmacol 262:65-75

Showing the most recent 10 out of 32 publications